AGP Executive Report
Last update: 3 hours agoHealthcare Shake-up: CVS plans to split its insurance, pharmacy-benefit and care-services businesses from its retail pharmacies and clinics, with the separation expected in 2028. The company says shoppers’ pharmacy experience and prescription costs will not change. Cancer Detection: England will test whether blood tests can help GPs identify several abdominal cancers earlier. The trial will involve more than 20,000 patients at 200 practices. Drug Supply Rules: Pharma manufacturers are seeking clarity on new batch-by-batch clearance requirements for certain solvents, warning that approval delays could disrupt supplies, particularly for exporters. Weight-Loss Treatment: Novo Nordisk’s oral Wegovy generated $813 million in third-quarter sales, helping the company raise its 2026 outlook even as sales of its injectable obesity drugs fell. Cell Therapy: A study of 580 lymphoma patients linked higher levels of naive-like T cells in CAR T products to longer periods without disease progression, without a rise in severe side effects.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
